These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23014900)

  • 21. Provisional hybrid 2-stent Strategy utilizing bioresorbable vascular scaffold and drug-eluting metal stent: "T-stenting and small protrusion" technique.
    Miyazaki T; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):682-5. PubMed ID: 25510349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial observation of drug-eluting absorbable metal scaffold: multi-imaging modality assessment.
    Waksman R; Prati F; Bruining N; Haude M; Böse D; Kitabata H; Erne P; Verheye S; Degen H; Vermeersch P; Di Vito L; Koolen J; Erbel R
    Circ Cardiovasc Interv; 2013 Dec; 6(6):644-53. PubMed ID: 24254708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial.
    Dudek D; Onuma Y; Ormiston JA; Thuesen L; Miquel-Hebert K; Serruys PW
    EuroIntervention; 2012 Jan; 7(9):1060-1. PubMed ID: 21959320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.
    Brugaletta S; Gomez-Lara J; Bruining N; Radu MD; van Geuns RJ; Thuesen L; McClean D; Koolen J; Windecker S; Whitbourn R; Oberhauser J; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    EuroIntervention; 2012 Jul; 8(3):352-8. PubMed ID: 22130182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
    Pichette M; Chevalier F; Généreux P
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary spasm revascularized with a bioresorbable vascular scaffold.
    Bil J; Pawlowski T; Gil RJ
    Coron Artery Dis; 2015 Nov; 26(7):634-6. PubMed ID: 26267749
    [No Abstract]   [Full Text] [Related]  

  • 27. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
    Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting.
    Pan M; Medina A; Suárez de Lezo J; Romero M; Segura J; Martín P; Suárez de Lezo J; Hernandez E; Mazuelos F; Ojeda S
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1165-70. PubMed ID: 22511299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.
    Applegate RJ; Hermiller JJ; Sanz M; Doostzadeh J; Pierson W; Su X; Lansky AJ; Sudhir K; Stone GW
    EuroIntervention; 2010 Sep; 6(4):437-46. PubMed ID: 20884430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography.
    Grasso C; Attizzani GF; Patané M; Ohno Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Oct; 168(4):4490-1. PubMed ID: 23890924
    [No Abstract]   [Full Text] [Related]  

  • 31. Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Latib A; Colombo A
    Int J Cardiol; 2014 Dec; 177(2):607-9. PubMed ID: 25443250
    [No Abstract]   [Full Text] [Related]  

  • 32. Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?
    Karanasos A; Simsek C; Serruys P; Ligthart J; Witberg K; van Geuns RJ; Sianos G; Zijlstra F; Regar E
    Circulation; 2012 Aug; 126(7):e89-91. PubMed ID: 22891170
    [No Abstract]   [Full Text] [Related]  

  • 33. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention).
    Stefanini GG; Serruys PW; Silber S; Khattab AA; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; Di Mario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli AL; Gobbens P; Windecker S
    J Am Coll Cardiol; 2011 May; 57(22):2221-32. PubMed ID: 21616282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
    Brugaletta S; Garcia-Garcia HM; Diletti R; Gomez-Lara J; Garg S; Onuma Y; Shin ES; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Chevalier B; McClean D; Windecker S; Whitbourn R; Dorange C; Veldhof S; Rapoza R; Sudhir K; Bruining N; Ormiston JA; Serruys PW
    EuroIntervention; 2011 Apr; 6(9):1110-6. PubMed ID: 21518685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioresorbable Scaffolds for Coronary Artery Disease.
    Nathan A; Kobayashi T; Kolansky DM; Wilensky RL; Giri J
    Curr Cardiol Rep; 2017 Jan; 19(1):5. PubMed ID: 28108898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
    Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ;
    Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation.
    Kuramitsu S; Iwabuchi M; Haraguchi T; Domei T; Nagae A; Hyodo M; Yamaji K; Soga Y; Arita T; Shirai S; Kondo K; Ando K; Sakai K; Goya M; Takabatake Y; Sonoda S; Yokoi H; Toyota F; Nosaka H; Nobuyoshi M
    Circ Cardiovasc Interv; 2012 Oct; 5(5):663-71. PubMed ID: 23011266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?
    Brugaletta S; Heo JH; Garcia-Garcia HM; Farooq V; van Geuns RJ; de Bruyne B; Dudek D; Smits PC; Koolen J; McClean D; Dorange C; Veldhof S; Rapoza R; Onuma Y; Bruining N; Ormiston JA; Serruys PW
    Eur Heart J; 2012 Jun; 33(11):1325-33. PubMed ID: 22507972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold.
    Brown AJ; McCormick LM; Hoole SP; West NE
    JACC Cardiovasc Interv; 2013 Jul; 6(7):e41-2. PubMed ID: 23866193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.